About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 139763, 6 pages
http://dx.doi.org/10.1155/2013/139763
Research Article

Ursodeoxycholic Acid Improves Bilirubin but Not Albumin in Primary Biliary Cirrhosis: Further Evidence for Nonefficacy

1The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital and UCL Institute of Liver and Digestive Health, London NW3 2QG, UK
2UK Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK

Received 30 April 2013; Accepted 7 July 2013

Academic Editor: Senthil K. Venugopal

Copyright © 2013 Emmanuel A. Tsochatzis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Kaplan and M. E. Gershwin, “Primary biliary cirrhosis,” The New England Journal of Medicine, vol. 353, no. 12, pp. 1261–1273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. A. Tsochatzis, K. S. Gurusamy, C. Gluud, and A. K. Burroughs, “Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines,” Journal of Hepatology, vol. 51, no. 6, pp. 1084–1085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Gluud and E. Christensen, “Ursodeoxycholic acid for primary biliary cirrhosis,” Cochrane Database of Systematic Reviews, no. 1, p. CD000551, 2002. View at Scopus
  4. Y. Gong, Z. B. Huang, E. Christensen, and C. Gluud, “Ursodeoxycholic acid for primary biliary cirrhosis,” Cochrane Database of Systematic Reviews, no. 3, p. CD000551, 2008. View at Scopus
  5. J. Goulis, G. Leandro, and A. K. Burroughs, “Randomised controlled trials of ursodeoxychoric-acid therapy for primary biliary cirrhosis: a meta-analysis,” The Lancet, vol. 354, no. 9184, pp. 1053–1060, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Chan, J. R. Carpenter, C. Rigamonti, F. Gunsar, and A. K. Burroughs, “Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model,” Scandinavian Journal of Gastroenterology, vol. 40, no. 9, pp. 1081–1089, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Christensen, D. G. Altman, J. Neuberger et al., “Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model,” Gastroenterology, vol. 105, no. 6, pp. 1865–1876, 1993. View at Scopus
  8. E. R. Dickson, P. M. Grambsch, T. R. Fleming, L. D. Fisher, and A. Langworthy, “Prognosis in primary biliary cirrhosis: model for decision making,” Hepatology, vol. 10, no. 1, pp. 1–7, 1989. View at Scopus
  9. M. Buyse and G. Molenberghs, “Criteria for the validation of surrogate endpoints in randomized experiments,” Biometrics, vol. 54, no. 3, pp. 1014–1029, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. L. S. Freedman, B. I. Graubard, and A. Schatzkin, “Statistical validation of intermediate endpoints for chronic diseases,” Statistics in Medicine, vol. 11, no. 2, pp. 167–178, 1992. View at Scopus
  11. R. L. Prentice, “Surrogate endpoints in clinical trials: definition and operational criteria,” Statistics in Medicine, vol. 8, no. 4, pp. 431–440, 1989. View at Scopus
  12. R. E. Poupon, B. Balkau, E. Eschwege, and R. Poupon, “A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis,” The New England Journal of Medicine, vol. 324, no. 22, pp. 1548–1554, 1991. View at Scopus
  13. P. M. Battezzati, M. Podda, F. B. Bianchi et al., “Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial,” Journal of Hepatology, vol. 17, no. 3, pp. 332–338, 1993. View at Scopus
  14. M. Vuoristo, M. Färkkilä, A. Karvonen et al., “A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid,” Gastroenterology, vol. 108, no. 5, pp. 1470–1478, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Pares, L. Caballeria, J. Rodes, et al., “Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver,” Journal of Hepatology, vol. 32, pp. 561–566, 2000.
  16. G. V. Papatheodoridis, E. S. Hadziyannis, M. Deutsch, and S. J. Hadziyannis, “Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial,” American Journal of Gastroenterology, vol. 97, no. 8, pp. 2063–2070, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. D. Hughes, C. L. Raskino, S. J. Pocock, M. R. Biagini, and A. K. Burroughs, “Prediction of short-term survival with an application in primary biliary cirrhosis,” Statistics in Medicine, vol. 11, no. 13, pp. 1731–1745, 1992. View at Scopus
  18. C.-W. Chan, E. A. Tsochatzis, J. R. Carpenter, C. Rigamonti, F. Gunsar, and A. K. Burroughs, “Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 5, pp. 573–582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Goldstein, W. Browne, and J. Rasbash, “Multilevel modelling of medical data,” Statistics in Medicine, vol. 21, no. 21, pp. 3291–3315, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Combes, R. L. Carithers Jr., W. C. Maddrey et al., “A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis,” Hepatology, vol. 22, no. 3, pp. 759–766, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. L. S. Eriksson, R. Olsson, H. Glauman et al., “Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study,” Scandinavian Journal of Gastroenterology, vol. 32, no. 2, pp. 179–186, 1997. View at Scopus
  22. E. J. Heathcote, K. Cauch-Dudek, V. Walker et al., “The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis,” Hepatology, vol. 19, no. 5, pp. 1149–1156, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Leuschner, H. Fischer, W. Kurtz et al., “Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial,” Gastroenterology, vol. 97, no. 5, pp. 1268–1274, 1989. View at Scopus
  24. K. D. Lindor, E. R. Dickson, W. P. Baldus et al., “Ursodeoxycholic acid in the treatment of primary biliary cirrhosis,” Gastroenterology, vol. 106, no. 5, pp. 1284–1290, 1994. View at Scopus
  25. I. B. Turner, M. Myszor, H. C. Mitchison, M. K. Bennett, A. D. Burt, and O. F. W. James, “A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 9, no. 2, pp. 162–168, 1994. View at Scopus
  26. T. Ikegami and Y. Matsuzaki, “Ursodeoxycholic acid: mechanism of action and novel clinical applications,” Hepatology Research, vol. 38, no. 2, pp. 123–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Chan, G. V. Papatheodoridis, J. Goulis, and A. K. Burroughs, “Ursodeoxycholic acid and histological progression in primary biliary cirrhosis,” Journal of Hepatology, vol. 39, no. 6, pp. 1094–1095, 2003. View at Publisher · View at Google Scholar · View at Scopus